Portal Login:
  • Clients
  • Providers
  • Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
    Portal Login:
  • Clients
  • Providers
  • About MCN
  • Careers
  • MCNTalk
  • Contact Us

MCN | Medical Consultants Network

The Power of a Second Look

  • Services
    • Independent Medical Examinations
    • Medical Peer Reviews
    • Bill Review Services
    • Utilization Reviews
  • Expertise
    • Short and Long-Term Disability
    • Workers’ Compensation
    • Auto/PIP/Casualty/Liability
    • Independent Review Organization Services
  • For Clients
  • For Providers
  • Your Exam
    • About Your Exam
    • About Your External Review
    • Contact & Scheduling
  • Schedule Now
  • About MCN
  • MCNTalk
  • Careers
  • Contact Us

MCNTalk
News, Insights & Opinions

Home / MCNTalk / The Potential Downside of Broad Cancer Screening

January 26, 2018

The Potential Downside of Broad Cancer Screening

Popular Science published a piece recently discussing advancements being made in cancer screening that could potentially allow for early detection of more forms of cancer and the debate within the medical community over how these tools will best serve patients. As cancer screening tools continue to improve, and much broader cancer screening may be available in the near future, medical professionals are finding themselves at odds about whether early detection is always best for the patient.

The article explains that while early detection of many forms of cancer will improve a patient’s odds of survival, medical professionals are grappling with the potential harm that could come from detection of pre-cancer and early cancer that wouldn’t ever do any harm to a patient during their lifetime as well as cancers that do not respond well to treatment, such as pancreatic cancer.

The piece goes on provide insight from physicians both for and against the advancement of these early detection tools. In the end, once these tests are available to the public it will be up to each individual to decide whether they would want to know they have a type of cancer that can’t or doesn’t need to be treated, but many of us will be looking to our physicians for their professional medical opinion to help us decide.

Share this:

  • Twitter
  • Email
  • More
  • Facebook
  • Reddit
  • Print

Leave a Comment

Previous Post
Next Post

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Posts

  • The Quality Divide: What Makes a Quality IME Physician?
  • The Quality Divide: Is Your Vendor Driving IME Excellence?
  • The Quality Divide: When and How to Request an IME?
  • April Clinic Calendars Are Available
  • MCN’s Client Portal Login Page is Changing

Archives

Footer


  • Twitter
  • LinkedIn

Quick Links

  • Services
  • Expertise
  • About MCN
  • Careers

Division Headquarters

MCN
1200 5th Ave., Ste. 650
Seattle, WA 98101

See all offices

Email Us

General Inquiries: info@mcn.com
Sales & Marketing: marketing@mcn.com

Call Us

206.343.6100
800.248.6269

© Copyright 2023 Mitchell International, Inc. All Rights Reserved.

  • Privacy Policy
  • Sitemap